ARTICLE | Company News
Nymox Pharmaceuticals Corp., Specialty Laboratories Inc. deal
February 8, 1999 8:00 AM UTC
Specialty acquired an exclusive license for the reference laboratory market to NMX's AD7C urine test to diagnose Alzheimer's disease (AD). In addition, Specialty has an exclusive license to conduct cl...